3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
3
Melanoma
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Signs and Symptoms
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
dabrafenib
2
binimetinib
2
Surveys and Questionnaires
2
Sunitinib
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Cetuximab
2
Biopsy
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
temsirolimus
1
selpercatinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
gallium Ga 68 dotatate
1
erdafitinib
1
defactinib
1
copanlisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Methods
×
30 days
×
Clear all
No trials found.